Literature DB >> 20107996

PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.

Dong I Lee1, Susan Vahebi, Carlo Gabriele Tocchetti, Lili A Barouch, R John Solaro, Eiki Takimoto, David A Kass.   

Abstract

Phosphodiesterase type 5A (PDE5A) inhibitors acutely suppress beta-adrenergic receptor (beta-AR) stimulation in left ventricular myocytes and hearts. This modulation requires cyclic GMP synthesis via nitric oxide synthase (NOS)-NO stimulation, but upstream and downstream mechanisms remain un-defined. To determine this, adult cardiac myocytes from genetically engineered mice and controls were studied by video microscopy to assess sarcomere shortening (SS) and fura2-AM fluorescence to measure calcium transients (CaT). Enhanced SS from isoproterenol (ISO, 10 nM) was suppressed >or=50% by the PDE5A inhibitor sildenafil (SIL, 1 microM), without altering CaT. This regulation was unaltered despite co-inhibition of either the cGMP-stimulated cAMP-esterase PDE2 (Bay 60-7550), or cGMP-inhibited cAMP-esterase PDE3 (cilostamide). Thus, the SIL response could not be ascribed to cGMP interaction with alternative PDEs. However, genetic deletion (or pharmacologic blockade) of beta3-ARs, which couple to NOS signaling, fully prevented SIL modulation of ISO-stimulated SS. Importantly, both PDE5A protein expression and activity were similar in beta3-AR knockout (beta3-AR(-/-)) myocytes as in controls. Downstream, cGMP stimulates protein kinase G (PKG), and we found contractile modulation by SIL required PKG activation and enhanced TnI phosphorylation at S23, S24. Myocytes expressing the slow skeletal TnI isoform which lacks these sites displayed no modulation of ISO responses by SIL. Non-equilibrium isoelectric focusing gel electrophoresis showed SIL increased TnI phosphorylation above that from concomitant ISO in control but not beta3-AR(-/-) myocytes. These data support a cascade involving beta3-AR stimulation, and subsequent PKG-dependent TnI S23, S24 phosphorylation as primary factors underlying the capacity of acute PDE5A inhibition to blunt myocardial beta-adrenergic stimulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107996      PMCID: PMC2878662          DOI: 10.1007/s00395-010-0084-5

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  46 in total

1.  Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.

Authors:  S Moniotte; L Kobzik; O Feron; J N Trochu; C Gauthier; J L Balligand
Journal:  Circulation       Date:  2001-03-27       Impact factor: 29.690

2.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions.

Authors:  B M Wolska; K Vijayan; G M Arteaga; J P Konhilas; R M Phillips; R Kim; T Naya; J M Leiden; A F Martin; P P de Tombe; R J Solaro
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

4.  Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure.

Authors:  H Senzaki; C J Smith; G J Juang; T Isoda; S P Mayer; A Ohler; N Paolocci; G F Tomaselli; J M Hare; D A Kass
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

5.  Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes.

Authors:  Joanne Layland; Jian-Mei Li; Ajay M Shah
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

6.  Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction.

Authors:  Paul B Massion; Chantal Dessy; Fanny Desjardins; Michel Pelat; Xavier Havaux; Catharina Belge; Pierre Moulin; Yves Guiot; Olivier Feron; Stefan Janssens; Jean-Luc Balligand
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

7.  Intracellular mechanisms of cGMP-mediated regulation of myocardial contraction.

Authors:  S Satoh; N Makino
Journal:  Basic Res Cardiol       Date:  2001-11       Impact factor: 17.165

8.  The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.

Authors:  Sergio E Martinez; Albert Y Wu; Natalie A Glavas; Xiao-Bo Tang; Stewart Turley; Wim G J Hol; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

9.  Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A.

Authors:  Albert Y Wu; Xiao-Bo Tang; Sergio E Martinez; Kaori Ikeda; Joseph A Beavo
Journal:  J Biol Chem       Date:  2004-06-21       Impact factor: 5.157

10.  Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.

Authors:  Jayan Nagendran; Stephen L Archer; Daniel Soliman; Vikram Gurtu; Rohit Moudgil; Alois Haromy; Chantal St Aubin; Linda Webster; Ivan M Rebeyka; David B Ross; Peter E Light; Jason R B Dyck; Evangelos D Michelakis
Journal:  Circulation       Date:  2007-07-02       Impact factor: 29.690

View more
  45 in total

1.  Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.

Authors:  Kalkidan Bishu; Nazha Hamdani; Selma F Mohammed; Martina Kruger; Tomohito Ohtani; Ozgur Ogut; Frank V Brozovich; John C Burnett; Wolfgang A Linke; Margaret M Redfield
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  The role of cGMP-dependent protein kinase in controlling cardiomyocyte cGMP.

Authors:  Sharron H Francis
Journal:  Circ Res       Date:  2010-11-12       Impact factor: 17.367

3.  Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5.

Authors:  Manling Zhang; Eiki Takimoto; Steven Hsu; Dong I Lee; Takahiro Nagayama; Thomas Danner; Norimichi Koitabashi; Andreas S Barth; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  J Am Coll Cardiol       Date:  2010-10-21       Impact factor: 24.094

4.  Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.

Authors:  Clint L Miller; Yujun Cai; Masayoshi Oikawa; Tamlyn Thomas; Wolfgang R Dostmann; Manuela Zaccolo; Keigi Fujiwara; Chen Yan
Journal:  Basic Res Cardiol       Date:  2011-10-20       Impact factor: 17.165

5.  Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.

Authors:  Guangshuo Zhu; Dieter Groneberg; Gautam Sikka; Daijiro Hori; Mark J Ranek; Taishi Nakamura; Eiki Takimoto; Nazareno Paolocci; Dan E Berkowitz; Andreas Friebe; David A Kass
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

6.  Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.

Authors:  Gun-Sik Cho; Dong I Lee; Emmanouil Tampakakis; Sean Murphy; Peter Andersen; Hideki Uosaki; Stephen Chelko; Khalid Chakir; Ingie Hong; Kinya Seo; Huei-Sheng Vincent Chen; Xiongwen Chen; Cristina Basso; Steven R Houser; Gordon F Tomaselli; Brian O'Rourke; Daniel P Judge; David A Kass; Chulan Kwon
Journal:  Cell Rep       Date:  2017-01-10       Impact factor: 9.423

Review 7.  Oxidative stress and sarcomeric proteins.

Authors:  Susan F Steinberg
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 8.  Compartmentalization of β-adrenergic signals in cardiomyocytes.

Authors:  Qin Fu; Xiongwen Chen; Yang K Xiang
Journal:  Trends Cardiovasc Med       Date:  2013-03-23       Impact factor: 6.677

9.  BNP controls early load-dependent regulation of SERCA through calcineurin.

Authors:  Karl Toischer; Nils Teucher; Bernhard Unsöld; Michaela Kuhn; Harald Kögler; Gerd Hasenfuss
Journal:  Basic Res Cardiol       Date:  2010-08-15       Impact factor: 17.165

Review 10.  Heart failure with preserved ejection fraction: emerging drug strategies.

Authors:  Fouad A Zouein; Lisandra E de Castro Brás; Danielle V da Costa; Merry L Lindsey; Mazen Kurdi; George W Booz
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.